Visceral Artery Aneurysm Embolization by the Penumbra Ruby™ Coil System

Withdrawn before enrolling · Phase 4

Conditions studied: Visceral Artery Aneurysms, Arteriovenous Malformations

In brief

The primary objective of this study is to gather post market data on the Penumbra Ruby Coil System in the treatment of visceral artery aneurysms and arteriovenous malformations. This study is a prospective, multi-center study of patients with visceral artery aneurysms and visceral arteriovenous malformations who are treated by the Penumbra Ruby Coil System. Data for each patient are collected up to 12 months post-procedure for the study.

Key facts

Study ID

NCT02079818

Run by

Penumbra Inc.

People needed

0

Starts

2017-06-01

Expected to finish

2018-09-01

Last updated by the study team

2019-04-12

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients enrolled in this study must be those treated according to the cleared indication for the Penumbra Ruby Coil System for visceral arterial and venous embolizations.

You may not qualify if…

• Patients in whom endovascular embolization therapies other than Penumbra Coils are used will be excluded from this study.

Where it is running

• Medical College of Wisconsin — Milwaukee, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.